# FULVESTRANT

NDC: 16714-070
Generic name: fulvestrant
Labeler / Manufacturer: Northstar Rx, LLC,
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20210823

FDA application: ANDA213553

## Active ingredients

- FULVESTRANT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16714-070"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16714-070
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67566681-19b5-89df-2030-25df5b0cf641